ArticleBritish journal of pharmacology2011

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.

P Malherbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.